e-learning
resources
Milan 2017
Sunday, 10.09.2017
Update on community acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia.
M. Kolditz (Dresden, Germany)
Source:
International Congress 2017 – Update on community acquired pneumonia
Session:
Update on community acquired pneumonia
Session type:
Oral Presentation
Number:
469
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kolditz (Dresden, Germany). Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia.. 469
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 482s
Year: 2007
Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?
Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017
Year: 2017
Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia
Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia
Year: 2011
Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Performance of the CORB score for predicting clinical outcomes in community-acquired pneumonia.
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007
Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Procalcitonin and pneumonia severity scores fail to predict death in nursing home acquired pneumonia (NHAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Community-acquired pneumonia (CAP) in the elderly: Prediction of mortality by physical symptoms, laboratory values and radiographic features on admission
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia
Source: Eur Respir J 2009; 34: 932-939
Year: 2009
Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018
Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia
Source: Annual Congress 2011 - Early diagnosis in primary care
Year: 2011
Lactate is an independent marker of severity in hospitalised patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept